Patents by Inventor Jen-Chieh Tseng

Jen-Chieh Tseng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240119283
    Abstract: A method of performing automatic tuning on a deep learning model includes: utilizing an instruction-based learned cost model to estimate a first type of operational performance metrics based on a tuned configuration of layer fusion and tensor tiling; utilizing statistical data gathered during a compilation process of the deep learning model to determine a second type of operational performance metrics based on the tuned configuration of layer fusion and tensor tiling; performing an auto-tuning process to obtain a plurality of optimal configurations based on the first type of operational performance metrics and the second type of operational performance metrics; and configure the deep learning model according to one of the plurality of optimal configurations.
    Type: Application
    Filed: October 6, 2023
    Publication date: April 11, 2024
    Applicant: MEDIATEK INC.
    Inventors: Jui-Yang Hsu, Cheng-Sheng Chan, Jen-Chieh Tsai, Huai-Ting Li, Bo-Yu Kuo, Yen-Hao Chen, Kai-Ling Huang, Ping-Yuan Tseng, Tao Tu, Sheng-Je Hung
  • Publication number: 20160115458
    Abstract: Disclosed herein are methods for treating a mammal harboring a solid tumor which expresses higher levels of High Affinity Laminin Receptors (LAMR) than normal cells of the same lineage comprising systematically administering to a mammal in need of such treatment a therapeutically effective amount of a Replication Competent (RC) Sindbis virus vector, wherein said vector encodes a suicide gene.
    Type: Application
    Filed: October 13, 2015
    Publication date: April 28, 2016
    Inventors: Daniel Meruelo, Jen-Chieh Tseng
  • Publication number: 20160008431
    Abstract: A method for treating malignant tumors with Sindbis viral based vectors in combination with antitumor agents and pharmaceutical formulations for use in such treatment.
    Type: Application
    Filed: July 13, 2015
    Publication date: January 14, 2016
    Inventors: Daniel Meruelo, Tomer Granot, Jen-Chieh Tseng
  • Patent number: 8282916
    Abstract: Disclosed herein are methods for treating a mammal harboring a solid tumor which expresses higher levels of High Affinity Laminin Receptors (LAMR) than normal cells of the same lineage comprising systematically administering to a mammal in need of such treatment a therapeutically effective amount of a Replication Competent (RC) Sindbis virus vector, wherein said vector encodes a suicide gene.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: October 9, 2012
    Assignee: New York University
    Inventors: Daniel Meruelo, Jen-Chieh Tseng
  • Publication number: 20110318430
    Abstract: A method for treating malignant tumors with Sindbis viral based vectors in combination with antitumor agents and pharmaceutical formulations for use in such treatment.
    Type: Application
    Filed: December 18, 2009
    Publication date: December 29, 2011
    Applicant: NEW YORK UNIVERSITY
    Inventors: Daniel Meruelo, Tomer Granot, Jen-Chieh Tseng
  • Patent number: 7910093
    Abstract: Disclosed herein are methods for identifying cancer cells and monitoring anti-cancer therapy in the body of a mammal by systemically delivering Sindbis viral vectors. The vector can specifically target and identify tumor cells in mice growing subcutaneously, intraperitoneally, intrapancreatically, or in the lungs. These findings demonstrate the remarkable specificity of the Sindbis vector system that is relatively safe and can specifically target tumor cells throughout the body via the bloodstream.
    Type: Grant
    Filed: August 16, 2004
    Date of Patent: March 22, 2011
    Assignee: New York University
    Inventors: Daniel Meruelo, Jen-Chieh Tseng
  • Publication number: 20090214425
    Abstract: Disclosed herein are methods for treating a mammal harboring a solid tumor which expresses higher levels of High Affinity Laminin Receptors (LAMR) than normal cells of the same lineage comprising systematically administering to a mammal in need of such treatment a therapeutically effective amount of a Replication Competent (RC) Sindbis virus vector, wherein said vector encodes a suicide gene.
    Type: Application
    Filed: February 20, 2009
    Publication date: August 27, 2009
    Applicant: New York University
    Inventors: Daniel Meruelo, Jen-Chieh Tseng
  • Publication number: 20050152838
    Abstract: Disclosed herein are methods for identifying cancer cells and monitoring anti-cancer therapy in the body of a mammal by systemically delivering Sindbis viral vectors. The vector can specifically target and identify tumor cells in mice growing subcutaneously, intraperitoneally, intrapancreatically, or in the lungs. These findings demonstrate the remarkable specificity of the Sindbis vector system that is relatively safe and can specifically target tumor cells throughout the body via the bloodstream.
    Type: Application
    Filed: August 16, 2004
    Publication date: July 14, 2005
    Inventors: Daniel Meruelo, Jen-Chieh Tseng